Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Non-Current Debt: 2024

Historic Non-Current Debt for Eton Pharmaceuticals (ETON) over the last 1 years, with Dec 2024 value amounting to $29.8 million.

  • Eton Pharmaceuticals' Non-Current Debt was N/A to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year change of. This contributed to the annual value of $29.8 million for FY2024, which is N/A change from last year.
  • Per Eton Pharmaceuticals' latest filing, its Non-Current Debt stood at $29.8 million for FY2024.
  • In the past 5 years, Eton Pharmaceuticals' Non-Current Debt registered a high of $29.8 million during FY2024, and its lowest value of $29.8 million during FY2024.
  • For the 1-year period, Eton Pharmaceuticals' Non-Current Debt averaged around $29.8 million, with its median value being $29.8 million (2024).